Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - TripCo Outstanding Awards (Details)

v3.22.0.1
Stock-Based Compensation - TripCo Outstanding Awards (Details) - 2019 Plan - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Additional disclosures      
Unvested value not yet recognized $ 5,900    
Weighted average period the unrecognized compensation cost will be recognized 2 years    
Series A and B      
Additional disclosures      
Amount of share reserve 3,500    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Exercised 0 0 0
Stock Options | Series A      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding beginning balance 1,086    
Granted 72    
Forfeited/Cancelled (29)    
Outstanding ending balance 1,129 1,086  
Options exercisable 512    
WAEP      
Weighted average exercise price, options outstanding (in dollars per share) $ 7.78    
Weighted average exercise price, options granted (in dollars per share) 4.82    
Weighted average exercise price, options forfeited/cancelled (in dollars per share) 23.22    
Weighted average exercise price, options outstanding (in dollars per share) 7.20 $ 7.78  
Weighted average exercise price, options exercisable (in dollars per share) $ 10.47    
Weighted average remaining contractual term outstanding 5 years 1 month 6 days    
Weighted average remaining contractual term exercisable 4 years 2 months 12 days    
Stock Options | Series B      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding beginning balance 2,397    
Outstanding ending balance 2,397 2,397  
Options exercisable 2,397    
WAEP      
Weighted average exercise price, options outstanding (in dollars per share) $ 21.93    
Weighted average exercise price, options outstanding (in dollars per share) 21.93 $ 21.93  
Weighted average exercise price, options exercisable (in dollars per share) $ 21.93    
Weighted average remaining contractual term outstanding 3 years 8 months 12 days    
Weighted average remaining contractual term exercisable 3 years 8 months 12 days    
Outstanding, aggregate intrinsic value $ 8,000    
Exercisable, aggregate intrinsic value 8,000    
Stock Options | Series B | CEO      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted   573 27
Restricted Stock and Restricted Stock Units      
Additional disclosures      
Aggregate fair value $ 2,800 $ 554 $ 159
Restricted Stock and Restricted Stock Units | Series A and B      
Additional disclosures      
Unvested RSUs and MSUs (in shares) 1,700    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 5.21